Becton, Dickinson and Company (NYSE:BDX), a leading player in the medical technology sector with a market capitalization of ...
This was the stock's second consecutive day of gains.
6h
Abhijeet Bhardwaj's commitment to technical excellence and innovation continues to drive successful outcomes in large-scale ...
Four of our panelists discuss their favorite investments in the final installment of our 2025 stock-picking confab.
BD and Biosero collaborate to integrate robotic automation with flow cytometry technology, aiming to accelerate drug discovery.
Argus Research analyst David Toung maintained a Buy rating on Johnson & Johnson (JNJ – Research Report) yesterday. The company’s shares ...
Citi analyst Joanne Wuensch reiterated a Buy rating on Intuitive Surgical (ISRG – Research Report) yesterday and set a price target of $711.00.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback